November 21, 2021
Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from Xencor
May 3, 2021
Zenas BioPharma Announces New Executive Leadership Appointments
March 23, 2021
Zenas BioPharma Launches as a Cross-Border Biopharmaceutical Company to Bring Innovation to the Development and Delivery of Immune-Based Therapies